Study of Anlotinib in Patients With Metastatic Colorectal Cancer（mCRC）(ALTER0703)

NCT02332499 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

419

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Anlotinib
DRUG: Placebo

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.